SAFFARIEH, E.; NASSIRI, S.; MIRMOHAMMADKHANI, M. Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients. European Journal of Translational Myology, [S. l.], v. 32, n. 3, 2022. DOI: 10.4081/ejtm.2022.10671. Disponível em: https://www.pagepressjournals.org/bam/article/view/10671. Acesso em: 22 nov. 2024.